understanding abemaciclib: a new cdk4/6 inhibitor
Published 6 years ago • 2.7K plays • Length 2:27Download video MP4
Download video MP3
Similar videos
-
2:58
patients’ perspectives on cdk4/6 inhibitors
-
3:21
benefits and challenges of cdk4/6 inhibitors
-
4:35
hr breast cancer: differences between cdk4/6 inhibitors
-
5:50
the efficacy and safety of cdk4/6 inhibitors
-
5:34
considerations for treating patients with cdk4/6 inhibitors
-
9:18
clinical experience: cdk4/6 inhibitors in breast cancer
-
4:52
cdk4/6 inhibitor combinations for hr mbc
-
7:59
what are cdk 4/6 inhibitors for breast cancer?
-
7:17
abemaciclib for er mbc
-
5:16
cdk4/6 inhibitor abemaciclib plus fulvestrant improves overall survival in hr-positive/her2-nega...
-
1:41
dr. harold j. burstein on cdk4/cdk6 inhibitor abemaciclib in breast cancer
-
3:33
cdk 4/6 inhibitors in metastatic breast cancer
-
3:56
hr breast cancer: risk-stratifying to cdk4/6 inhibitors
-
2:24
differentiating factors of abemaciclib among the cdk 4/6 inhibitors for breast cancer
-
2:38
cdk4/6 inhibitors: the differential value of ribociclib
-
5:32
esmo 2020 expert video report on cdk4 6i in the adjuvant treatment of breast cancer
-
21:47
esmo daily reporter talk: the role of cdk4/6 inhibitors in the early stage of #breastcancer.
-
5:32
biomarkers for cdk4/6 inhibitors
-
5:47
monarche and pallas: a tale of two cdk4/6 inhibitors | george sledge jr